Processa pharmaceuticals ceo dr. david young to present at the oppenheimer 32nd annual healthcare conference

Hanover, md, march 10, 2022 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa), (“processa” or the “company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical need conditions, announced today that the company's ceo dr. david young, will present at the oppenheimer 32nd annual healthcare conference on march 17th, 2022 at 10:00 am eastern.
PCSA Ratings Summary
PCSA Quant Ranking